Juha Grönholm

Juha Grönholm

Auto-generated profile, based on publicly available information

Juha Grönholm

Translational Immunology Research Program, University of Helsinki, Helsinki, Finland

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2017 in Nature Immunology
Verified
Journal Article
Open access
PDF file
BABehdad Afzali
Behdad Afzali
JGJuha Grönholm
Juha Grönholm
JVJana Vandrovcova
Jana Vandrovcova
COCharlotte O'BRien
Charlotte O'BRien
HSHong-Wei Sun
Hong-Wei Sun
ALArian D J Laurence
Arian D J Laurence
BACH2 is required for lymphocyte differentiation. Afzali et al. describe mutations that cause BACH2 disruption, immunodeficiency and autoinflammatory disease via haploinsufficiency, a mechanism shared by other super-enhancer-regulated genes. The transcriptional programs that guide lymphocyte differentiation depend on the precise expression and timing of transcription factors (TFs). The TF BACH2 is essential for T and B lymphocytes and is associated with an archetypal super-enhancer (SE). Single-nucleotide variants in the BACH2 locus are associated with several autoimmune diseases, but BACH2 mutations that cause Mendelian monogenic primary immunodeficiency have not previously been identified. Here we describe a syndrome of BACH2-related immunodeficiency and autoimmunity (BRIDA) that results from BACH2 haploinsufficiency. Affected subjects had lymphocyte-maturation defects that caused immunoglobulin deficiency and intestinal inflammation. The mutations disrupted protein stability by interfering with homodimerization or by causing aggregation. We observed analogous lymphocyte defects in Bach2-heterozygous mice. More generally, we observed that genes that cause monogenic haploinsufficient diseases were substantially enriched for TFs and SE architecture. These findings reveal a previously unrecognized feature of SE architecture in Mendelian diseases of immunity: heterozygous mutations in SE-regulated genes identified by whole-exome/genome sequencing may have greater significance than previously recognized.

12 July 2010 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
JKJenni Kallio
Jenni Kallio
HMHenna Myllymaki
Henna Myllymaki
JGJuha Grönholm
Juha Grönholm
MAMorag Armstrong
Morag Armstrong
LVLeena‐Maija Vanha‐Aho
Leena‐Maija Vanha‐Aho
MRMika Rämet
Mika Rämet
JAK/STAT signaling pathway is evolutionarily conserved and tightly regulated. We carried out a reporter‐based genome‐wide RNAi in vitro screen to identify genes that regulate Drosophila JAK/STAT pathway and found 5 novel regulators. Of these, CG14225 is a negative regulator structurally related to the Drosophila JAK/STAT pathway receptor Domeless, especially in the extracellular domain, and to the mammalian IL‐6 receptor and the signal transducer gp130. CG14225 coimmunoprecipitates with Domeless and its associated kinase hopscotch in S2 cells. CG14225 RNAi caused hyperphosphorylation of the transcription factor Stat92E in S2 cells on stimulation with the Drosophila JAK/STAT pathway ligand unpaired. CG14225 RNAi in vivo hyperactivated JAK/STAT target genes on septic injury and enhanced unpaired‐induced eye overgrowth, and was thus named the eye transformer (ET) . In the gastrointestinal infection model, where JAK/STAT signaling is important for stem cell renewal, CG14225/ET RNAi was protective in vivo . In conclusion, we have identified ET as a novel negative regulator of the Drosophila JAK/STAT pathway both in vitro and in vivo , and it functions in regulating Stat92E phosphorylation.—Kallio, J., Myllymäki, H., Grönholm, J., Armstrong, M., Vanha‐aho, L.‐M., Mäkinen, L., Silvennoinen, O., Valanne, S., Rämet, M. Eye transformer is a negative regulator of Drosophila JAK/STAT signaling. FASEBJ . 24, 4467–4479 (2010). www.fasebj.org

1 July 2005 in Blood
Verified
Journal Article
Closed access
PDF file
DUDaniela Ungureanu
Daniela Ungureanu
SVSari Vanhatupa
Sari Vanhatupa
JGJuha GrönHolm
Juha GrönHolm
JPJorma J. Palvimo
Jorma J. Palvimo
OSOlli Silvennoinen
Olli Silvennoinen
Signal transducers and activators of transcription 1 (STAT1) is a critical mediator of interferon (IFN)–induced gene responses. Recently, STAT1 was found to become modified by small ubiquitin-like modifier 1 (SUMO-1) conjugation at Lys703 through the SUMO E3 ligase function of protein inhibitors of activated STAT (PIAS) proteins. However, the physiologic function of sumoylation in STAT1 is still unclear. Here, we show that mutations in the SUMO attachment site in STAT1 result in increased transcriptional activity in a fashion that is selective among IFN-γ target genes. The sumoylation-defective STAT1 mutant displayed increased induction of guanylate-binding protein 1 (GBP1) and transporters associated with antigen presentation 1 (TAP1) transcription but not interferon regulatory factor 1 (IRF1) transcription. Moreover, the sumoylation-defective mutant STAT1-KR showed a prolonged DNA-binding activity and nuclear localization in response to IFN-γ stimulation. These results suggest that sumoylation has a defined negative regulatory effect on selective STAT1-mediated transcription responses.

8 October 2012 in BMC Biochemistry
Verified
Journal Article
Open access
PDF file
JGJuha Grönholm
Juha Grönholm
SVSari Vanhatupa
Sari Vanhatupa
DUDaniela Ungureanu
Daniela Ungureanu
JVJouni Väliaho
Jouni Väliaho
TLTuomo Laitinen
Tuomo Laitinen
OSOlli Silvennoinen
Olli Silvennoinen
Background: STAT1 is an essential transcription factor for interferon-γ-mediated gene responses. A distinct sumoylation consensus site (ψKxE) 702IKTE705 is localized in the C-terminal region of STAT1, where Lys703 is a target for PIAS-induced SUMO modification. Several studies indicate that sumoylation has an inhibitory role on STAT1-mediated gene expression but the molecular mechanisms are not fully understood. Results: Here, we have performed a structural and functional analysis of sumoylation in STAT1. We show that deconjugation of SUMO by SENP1 enhances the transcriptional activity of STAT1, confirming a negative regulatory effect of sumoylation on STAT1 activity. Inspection of molecular model indicated that consensus site is well exposed to SUMO-conjugation in STAT1 homodimer and that the conjugated SUMO moiety is directed towards DNA, thus able to form a sterical hindrance affecting promoter binding of dimeric STAT1. In addition, oligoprecipitation experiments indicated that sumoylation deficient STAT1 E705Q mutant has higher DNA-binding activity on STAT1 responsive gene promoters than wild-type STAT1. Furthermore, sumoylation deficient STAT1 E705Q mutant displayed enhanced histone H4 acetylation on interferon-γ-responsive promoter compared to wild-type STAT1. Conclusions: Our results suggest that sumoylation participates in regulation of STAT1 responses by modulating DNA-binding properties of STAT1.

1 January 2018 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
SMSonia S. Majri
Sonia S. Majri
JFJill M. Fritz
Jill M. Fritz
AVAlejandro V. Villarino
Alejandro V. Villarino
LZLixin Zheng
Lixin Zheng
CKChrysi Kanellopoulou
Chrysi Kanellopoulou
MLMichael J. Lenardo
Michael J. Lenardo
Understanding the control of Ag restimulation-induced T cell death (RICD), especially in cancer immunotherapy, where highly proliferating T cells will encounter potentially large amounts of tumor Ags, is important now more than ever. It has been known that growth cytokines make T cells susceptible to RICD, but the precise molecular mediators that govern this in T cell subsets is unknown until now. STAT proteins are a family of transcription factors that regulate gene expression programs underlying key immunological processes. In particular, STAT5 is known to favor the generation and survival of memory T cells. In this study, we report an unexpected role for STAT5 signaling in the death of effector memory T (TEM) cells in mice and humans. TEM cell death was prevented with neutralizing anti–IL-2 Ab or STAT5/JAK3 inhibitors, indicating that STAT5 signaling drives RICD in TEM cells. Moreover, we identified a unique patient with a heterozygous missense mutation in the coiled-coil domain of STAT5B that presented with autoimmune lymphoproliferative syndrome–like features. Similar to Stat5b−/− mice, this patient exhibited increased CD4+ TEM cells in the peripheral blood. The mutant STAT5B protein dominantly interfered with STAT5-driven transcriptional activity, leading to global downregulation of STAT5-regulated genes in patient T cells upon IL-2 stimulation. Notably, CD4+ TEM cells from the patient were strikingly resistant to cell death by in vitro TCR restimulation, a finding that was recapitulated in Stat5b−/− mice. Hence, STAT5B is a crucial regulator of RICD in memory T cells in mice and humans.

8 December 2011 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
JGJuha Grönholm
Juha Grönholm
MKMeri Kaustio
Meri Kaustio
HMHenna Myllymaki
Henna Myllymaki
JKJenni Kallio
Jenni Kallio
JSJuha Saarikettu
Juha Saarikettu
MRMika Rämet
Mika Rämet
The JAK/STAT pathway is essential for organogenesis, innate immunity, and stress responses in Drosophila melanogaster. The JAK/STAT pathway and its associated regulators have been highly conserved in evolution from flies to humans. We have used a genome‐wide RNAi screen in Drosophila S2 cells to identify regulators of the JAK/STAT pathway, and here we report the characterization of Not4 as a positive regulator of the JAK/STAT pathway. Overexpression of Not4 enhanced Stat92E‐mediated gene responses in vitro and in vivo in Drosophila. Specifically, Not4 increased Stat92E‐mediated reporter gene activation in S2 cells; and in flies, Not4 overexpression resulted in an 8‐fold increase in Turandot M (TotM ) and in a 4‐fold increase in Turandot A (TotA ) stress gene activation when compared to wild‐type flies. Drosophila Not4 is structurally related to human CNOT4, which was found to regulate interferon‐γ‐ and interleukin‐4‐induced STAT‐mediated gene responses in human HeLa cells. Not4 was found to coimmunoprecipitate with Stat92E but not to affect tyrosine phosphorylation of Stat92E in Drosophila cells. However, Not4 is required for binding of Stat92E to its DNA recognition sequence in the TotM gene promoter. In summary, Not4/CNOT4 is a novel positive regulator of the JAK/STAT pathway in Drosophila and in humans.—Grönholm, J., Kaustio, M., Myllymäki, H., Kallio, J., Saarikettu, J., Kronhamn, J., Valanne, S., Silvennoinen, O., Rämet, M. Not4 enhances JAK/STAT pathway‐dependent gene expression in Drosophila and in human cells. FASEB J. 26, 1239‐1250 (2012). www.fasebj.org